(Q44464287)

3 December 2017

title

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection (English)

1 reference

3 December 2017

0 references

0 references

1 reference

hepatocellular carcinoma

1 reference

1 reference

1 reference

1 reference

1 reference

Kazuyuki Ohata

1

1 reference

3 December 2017

Keisuke Hamasaki

2

1 reference

3 December 2017

Kan Toriyama

3

1 reference

3 December 2017

Kojiro Matsumoto

4

1 reference

3 December 2017

Akira Saeki

5

1 reference

3 December 2017

Kenji Yanagi

6

1 reference

3 December 2017

Seigou Abiru

7

1 reference

3 December 2017

Yuichi Nakagawa

8

1 reference

3 December 2017

Masaya Shigeno

9

1 reference

3 December 2017

Seiji Miyazoe

10

1 reference

3 December 2017

Tatsuki Ichikawa

11

1 reference

3 December 2017

Hiroki Ishikawa

12

1 reference

3 December 2017

Kazuhiko Nakao

13

1 reference

3 December 2017

Katsumi Eguchi

14

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

97

1 reference

3 December 2017

issue

12

1 reference

3 December 2017

page(s)

3036-3043

1 reference

Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki Prefecture, Japan

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Increase in primary liver cancer in the UK, 1979-94

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Trends in primary liver cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Irregular regeneration of hepatocytes is an important factor in the hepatocarcinogenesis of liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

The pathology of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Histopathology of chronic hepatitis C in relation to epidemiological factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Histopathology of Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Prevalence of and risk factors for hepatic steatosis in Northern Italy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Association between nonalcoholic fatty liver, markers of obesity, and serum leptin level in young adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Metformin reverses fatty liver disease in obese, leptin-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Steatosis and intrahepatic hepatitis C virus in chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11427

7 January 2021

Identifiers

DOI

10.1002/CNCR.11427

1 reference

3 December 2017

1 reference